Stratistics MRC에 따르면 세계의 오메가 3 시장은 2025년 107억 6,000만 달러를 차지하고 예측 기간 동안 CAGR 16.7%로 성장하여 2032년까지는 317억 2,000만 달러에 이를 것으로 예측됩니다.
오메가 3 지방산은 많은 신체 기능을 지원하는 필수 영양소이며, 심장, 뇌, 눈 건강에 대한 이점은 충분히 문서화되어 있습니다. 오메가 3 지방산은 인체에서 효율적으로 합성 할 수 없기 때문에 정기적 인 섭취가 필요합니다. 또한 오메가 3 지방산은 심장혈관 건강을 지원하고 인지 기능을 높이고 염증을 억제하며 관절염과 심장 질환과 같은 만성 질환의 위험을 줄일 수 있음이 연구에서 입증되었습니다.
미국 심장 협회(AHA)에 따르면 오메가 3 지방산은 심장혈관 건강에 중요한 역할을 합니다. AHA는 중성지방치가 높은 사람에게 의사의 지도하에 EPA와 DHA를 합쳐서 하루 2그램에서 4그램 섭취함으로써 중성지방을 20%에서 40% 효과적으로 저하시키는 것을 권고합니다.
건강에 대한 지식 증가
오메가 3 지방산, 특히 EPA와 DHA는 심장 건강을 지원하고 염증을 억제하고 뇌의 발달을 돕고 시력을 개선하는 역할에 대해 철저히 연구되어 왔습니다. 한층 더 견고한 것으로 하고 있습니다. 세계의 소비자의 건강 의식이 높아짐에 따라, 예방 헬스케어나 영양 솔루션에 대한 수요가 높아지고 있습니다. 또한, 미래를 전망한 건강 관리에 대한 시프트가, 오메가 3계 보충제나 강화 식품을 일상생활에 도입하는 사람들을 뒷받침하고 있습니다.
높은 생산 비용과 최종 제품 비용
고품질의 오메가 3 지방산, 특히 EPA와 DHA를 해양 자원에서 추출, 정제, 안정화하는 것은 고가의 작업입니다. 오메가 3를 강화한 제품과 보충제는 다른 영양 보충제와 비교할 때 상대적으로 비쌉니다.
식물과 조류 유래 오메가 3에 대한 요구 증가
채식주의와 식물 기반의 식생활이 세계에서 인기를 모으고 있는 것으로부터, 동물성이 아닌 오메가 3원에 수요가 높아지고 있습니다. 조류는 관리된 환경에서 재배할 수 있기 때문에 환경에 대한 영향이 적고, 일관성과 확장성이 있습니다. 또한, 식품, 음료, 영양 보조 식품 시장에 있어서의 식물 유래의 오메가 3 제제의 확대는 클린 라벨 제품이나 알레르겐 프리 보충제에 대한 수요의 높아지게 되고 있습니다.
높은 가격 압력과 시장 경쟁
시장은 현재 오메가 3의 인기가 높아지면서 다국적 대기업, 영양 보조 식품 회사, 현지 공급자, 프라이빗 브랜드가 혼재해, 매우 경쟁이 격렬해지고 있습니다. 따라서, 특히 중소기업에 있어서는 이익률이 압박되어 저가격으로 동등의 상품을 제공하는 유명 브랜드와 경쟁하는 것이 어려워지고 있습니다. 또한, 제품의 차별화가 어려워짐에 따라, 두드러진 존재가 되기 위해, 기업은 브랜딩, 혁신, 인증에 더욱 투자할 필요가 있습니다.
COVID-19의 대유행은 오메가 3 시장에 다양한 영향을 주었지만, 결국 좋은 방향으로 향했습니다. 이에 따라 오메가 3 제품과 같은 영양 보충제의 소비는 극적으로 증가했습니다. 또한 EPA와 DHA가 면역, 호흡기, 심장혈관 건강을 어떻게 지원하는지에 대한 지식이 깊어졌으며 특히 소비자에게 직접 판매하고 전자상거래를 통해 소비량 증가에 박차가 걸렸습니다.
예측 기간 동안 도코사헥사엔산(DHA) 부문이 최대가 될 전망
도코사헥사엔산(DHA) 부문은 특히 임산부와 유아의 뇌 개척, 인지 기능, 시각 건강에 중요한 역할을 하기 때문에 예측 기간 동안 최대 시장 점유율을 차지할 것으로 예측됩니다. 또한 기억력을 향상시키고 신경 퇴행성 질환의 위험을 낮추기 때문에 노인들에게도 편리합니다.
영양보조식품 분야는 예측기간 중 가장 높은 CAGR이 예상된다.
예측 기간 동안 영양 보조 식품 분야가 가장 높은 성장률을 보일 것으로 예측됩니다. 인구 고령화, 피트니스 및 웰빙 동향의 인기가 높아지고, 예방 건강 관리에 대한 욕구 증가는 모두 이 시장을 지원합니다. 또한, 오메가 3 영양 보조 식품은 구미, 소프트젤, 캡슐의 형태로 사용하기 쉽고 편리하기 때문에 매우 인기가 있습니다.
예측 기간 동안 북미가 가장 큰 시장 점유율을 차지할 것으로 예측됩니다. 의료 인프라가 정비되어 있기 때문에 오메가 3 제품은 쉽게 입수할 수 있습니다.
예측기간 중 아시아태평양은 가장 높은 CAGR을 나타낼 것으로 예측되며, 중국, 인도, 일본 등 국가에서는 가처분소득 증가, 건강지향 증가, 영양보조식품 수요 증가가 그 원동력이 되고 있습니다. 또한, 예방 헬스 케어의 중시와 심혈관 질환 등의 만성 질환 증가가 오메가 3계 보충제 수요를 밀어 올리고 있습니다.
According to Stratistics MRC, the Global Omega-3 Market is accounted for $10.76 billion in 2025 and is expected to reach $31.72 billion by 2032 growing at a CAGR of 16.7% during the forecast period. Omega-3 fatty acids are essential nutrients that support numerous bodily functions, with well-documented benefits for heart, brain, and eye health. Plant sources like flaxseeds and walnuts, as well as fatty fish like salmon and mackerel, are common sources of these polyunsaturated fats. Regular consumption of omega-3 fatty acids is required because the human body is unable to synthesize them effectively. Moreover, studies have demonstrated that omega-3 fatty acids support cardiovascular health, enhance cognitive function, reduce inflammation, and may even reduce the risk of chronic conditions like arthritis and heart disease.
According to the American Heart Association (AHA), omega-3 fatty acids play a significant role in cardiovascular health. The AHA recommends that adults consume at least two servings of fatty fish per week, such as salmon, mackerel, or sardines, to obtain these beneficial nutrients. For individuals with elevated triglyceride levels, the AHA advises a daily intake of 2 to 4 grams of EPA and DHA combined, under medical supervision, to effectively lower triglycerides by 20% to 40%.
Increasing knowledge of health
Omega-3 fatty acids, particularly EPA and DHA, have been thoroughly studied for their role in supporting heart health, reducing inflammation, aiding brain development, and improving vision. Public health campaigns and endorsements from medical organizations like the American Heart Association have further solidified the role of omega-3s in maintaining long-term wellness. As consumers around the world become more health-conscious, there is an increasing demand for preventive healthcare and nutritional solutions. Additionally, this shift toward proactive health management is propelling people to incorporate omega-3 supplements or enriched foods into their daily routine.
High production and final product costs
High-quality omega-3 fatty acid extraction, purification, and stabilization-particularly EPA and DHA-from marine sources are expensive procedures. Supercritical CO2 extraction and molecular distillation are two efficient but costly technologies. Fish from regulated fisheries or algae grown in controlled conditions also raise the cost of production. Omega-3-enriched products and supplements are relatively expensive when compared to other nutritional alternatives because these costs are frequently passed on to consumers. Furthermore, the penetration of the mass market may be restricted by this high price point, especially in developing nations where consumers are price sensitive.
Growing need for omega-3s derived from plants and algae
Demand for non-animal omega-3 sources is rising as veganism and plant-based diets continue to gain popularity around the world. Vegetarians, vegans, and consumers who care about the environment are drawn to algae-derived omega-3s because they provide a sustainable and moral substitute for fish oil. These omega-3s are especially high in DHA. Because algae can be grown in controlled settings, there is less of an impact on the environment and consistency and scalability. Moreover, the expansion of plant-based omega-3 formulations in the food, beverage, and nutraceutical markets is further supported by the growing demand for clean-label products and allergen-free supplements.
High levels of price pressure and market competition
The market is now very competitive, with a mix of big multinational corporations, nutraceutical firms, local suppliers, and private-label brands due to the increasing popularity of omega-3s. As a result, basic omega-3 products have become commoditized, forcing businesses to adopt aggressive pricing strategies. Profit margins are therefore under pressure, particularly for smaller businesses that find it difficult to compete with well-known brands that provide comparable goods at lower prices. Furthermore, in order to stand out, businesses must invest more in branding, innovation, and certifications as product differentiation becomes more challenging.
The COVID-19 pandemic affected the Omega-3 market in a variety of ways, but ultimately for the better. Supply chain interruptions and logistical limitations initially impacted raw material availability, especially fish oil, and caused production and distribution delays. Consumption of dietary supplements, such as Omega-3 products, increased dramatically as the pandemic spread because consumers' priorities changed to immunity, preventive health, and general wellness. Moreover, higher consumption was fuelled by greater knowledge of how EPA and DHA support immune, respiratory, and cardiovascular health, especially through direct-to-consumer and e-commerce channels.
The docosahexaenoic acid (DHA) segment is expected to be the largest during the forecast period
The docosahexaenoic acid (DHA) segment is expected to account for the largest market share during the forecast period because of the vital role it plays in brain development, cognitive function, and visual health, especially in pregnant women and infants. DHA is a common ingredient in baby formulas, prenatal vitamins, and fortified foods. It is also valued in the elderly population for its ability to improve memory and lower the risk of neurodegenerative diseases. Additionally, the most prominent and economically significant market segment is DHA due to its high level of clinical validation and high consumer awareness of its neurological benefits.
The dietary supplements segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dietary supplements segment is predicted to witness the highest growth rate. The demand for Omega-3 supplements has been driven by rising consumer awareness of the health advantages of Omega-3, such as its beneficial effects on heart health, cognitive function, and inflammation reduction. The aging of the world's population, the growing popularity of fitness and wellness trends, and the growing desire for preventative healthcare all help this market. Furthermore, Omega-3 dietary supplements are very popular due to their ease of use and convenience in the form of gummies, soft gels, and capsules.
During the forecast period, the North America region is expected to hold the largest market share. The high level of consumer awareness of Omega-3's health benefits-particularly for heart health, cognitive function, and inflammation management-fuels this region's prevalence. Moreover, Omega-3 products are easily accessible due to the established healthcare infrastructure in North America. The aging of the population and the growing trend of preventive healthcare further fuel demand for Omega-3 supplements, making North America the region with the biggest and fastest-growing market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven in nations like China, India, and Japan by rising disposable incomes, growing health consciousness, and growing demand for dietary supplements. Omega-3 product consumption is rising in the region due to the growing middle class and shifting dietary preferences, including a move toward healthier, Western-style diets. Additionally, the growing emphasis on preventive healthcare and the rise of chronic diseases such as cardiovascular conditions are propelling the demand for Omega-3 supplements. The region's market is expanding quickly due in large part to the growth of e-commerce and improved access to foods enriched with omega-3 fatty acids.
Key players in the market
Some of the key players in Omega-3 Market include BASF SE, Rabar Pty Ltd, Croda International Plc, Omega Protein Corporation, ADM, Lonza Group, Kerry Group Plc, Glanbia Plc, Sinomega Biotech Engineering Co. Ltd., Cargill, Incorporated, Algisys LLC, Polaris, Koninklijke DSM N.V., Kinomega Biopharm Inc. and SternVitamin GmbH & Co. KG.
In March 2025, ADM and Mitsubishi Corporation have signed an agreement. This agreement is a non-binding memorandum of understanding. The companies will form a strategic alliance. They will explore potential areas for future collaboration. This collaboration will span the agriculture value chain. The importance of secure food supply chains has increased recently.
In October 2024, BASF, AM Green ink MoU for low-carbon chemical production in India. The agreement was signed by Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF SE, and Mahesh Kolli, Group President of AM Green, during the Asia-Pacific Conference of German Business 2024 held in New Delhi.
In March 2024, Croda International has entered a collaboration agreement with the Access to Advanced Health Institute (AAHI) to innovate and develop vaccine adjuvant formulations. Under this deal, the parties will use their combined capabilities to make new vaccine adjuvants accessible worldwide. This approach will aid in the advancement of next-generation vaccines that are robust and durable.